Cardiovascular effects of melanocortins

Area of Science:

• Endocrinology
• Physiology
• Cardiovascular Research

Background:

• Melanocortins (MSH), derived from proopiomelanocortin, regulate energy, appetite, and inflammation.
• Emerging evidence highlights MSH peptides, especially gamma-MSH (γ-MSH), in sodium metabolism and blood pressure control.

Purpose of the Study:

• To investigate the role of γ-MSH signaling in salt-sensitive hypertension and associated metabolic changes in rodents.
• To elucidate the mechanisms underlying γ-MSH's effects on blood pressure and sodium excretion.

Main Methods:

• Utilized rodent models with genetic or pharmacologic deficiencies in γ-MSH signaling.
• Examined blood pressure, plasma γ-MSH levels, and urinary sodium excretion in response to high-sodium diets.
• Investigated the effects of exogenous γ-MSH administration and α-adrenoceptor antagonists.
• Assessed insulin resistance in rodent models with disrupted γ-MSH signaling.

Main Results:

• Rodents with impaired γ-MSH signaling develop salt-sensitive hypertension, which is reversed by exogenous γ-MSH.
• γ-MSH deficiency leads to increased noradrenergic activity and salt sensitivity.
• Physiological γ-MSH levels promote sodium excretion via the melanocortin 3 receptor (Mc3r), while high levels can raise blood pressure through other receptors.
• Salt-sensitive hypertension in these models is linked to insulin resistance.

Conclusions:

• γ-MSH signaling is crucial for maintaining normotension and normal sodium balance, particularly under high-salt conditions.
• Disruptions in γ-MSH pathways contribute to salt-sensitive hypertension and insulin resistance, suggesting a link to type II diabetes.
• Targeting γ-MSH pathways may offer novel therapeutic strategies for hypertension and metabolic disorders.